PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.1 AUD
5.26%
Market Closed
Updated:
May 15, 2024
PYC Therapeutics Ltd
Research & Development
|
PYC Therapeutics Ltd
Research & Development Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Research & Development
-AU$39m
|
CAGR 3-Years
-117%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-32%
|
|
|
Immutep Ltd
ASX:IMM
|
Research & Development
-AU$37.7m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-11%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Research & Development
-$25.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Research & Development
-$1.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-11%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Research & Development
-AU$1.4m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
21%
|
CAGR 10-Years
5%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Research & Development
-AU$128.8m
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Research & Development?
Research & Development
-39m
AUD
-39m
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Research & Development amounts to -39m AUD.
What is PYC Therapeutics Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-32%
-32%
Over the last year, the Research & Development growth was -20%. The average annual Research & Development growth rates for PYC Therapeutics Ltd have been -117% over the past three years , -49% over the past five years , and -32% over the past ten years .
You don't have any saved screeners yet
